BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 8581290)

  • 1. Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.
    Piot O; Betschart J; Grall I; Ravard S; Garret C; Blanchard JC
    Br J Pharmacol; 1995 Nov; 116(5):2496-502. PubMed ID: 8581290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
    Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
    Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
    Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
    Floch A; Fardin V; Cavero I
    Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus.
    Zeng XP; Burcher E
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1295-300. PubMed ID: 7523658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
    Ahluwalia A; Giuliani S; Maggi CA
    Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat.
    Cellier E; Barbot L; Iyengar S; Couture R
    Br J Pharmacol; 1999 Jun; 127(3):717-28. PubMed ID: 10401563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for tachykinin NK-2 receptors in guinea-pig airways from binding and functional studies, using [125I]-[Lys5,Tyr(I2)7,MeLeu9,Nle10]-NKA(4-10).
    Zeng XP; Lavielle S; Burcher E
    Neuropeptides; 1994 Jan; 26(1):1-9. PubMed ID: 7512696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of septide-sensitive tachykinin receptors in inositol phospholipid hydrolysis in the rat urinary bladder.
    Torrens Y; Beaujouan JC; Saffroy M; Glowinski J
    Peptides; 1995; 16(4):587-94. PubMed ID: 7479288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
    Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
    Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E; Barbot L; Regoli D; Couture R
    Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
    Tauer U; Zhao Y; Hunt SP; Culman J
    Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
    Meini S; Patacchini R; Maggi CA
    Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    Deschamps K; Couture R
    Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice.
    Ravard S; Betschart J; Fardin V; Flamand O; Blanchard JC
    Brain Res; 1994 Jul; 651(1-2):199-208. PubMed ID: 7522932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence that NK-2 tachykinin receptors mediate hypotension in the guinea pig but not in the rat.
    Floch A; Thiry C; Cavero I
    Fundam Clin Pharmacol; 1996; 10(4):337-43. PubMed ID: 8871132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum.
    Petitet F; Saffroy M; Torrens Y; Glowinski J; Beaujouan JC
    Eur J Pharmacol; 1993 Oct; 247(2):185-91. PubMed ID: 7506659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.